期刊
TIERAERZTLICHE PRAXIS AUSGABE KLEINTIERE HEIMTIERE
卷 47, 期 2, 页码 112-118出版社
GEORG THIEME VERLAG KG
DOI: 10.1055/a-0858-4261
关键词
Drugs; registration; Lotilaner; Tramadol; Meloxicam; Sevoflurane; dogs; cats
In 2018, two active pharmaceutical ingredients were released on the German market for small animals: the ectoparasiticide of the isoxazoline group Lotilaner (Credelio (R)) and the opioid analgesic Tramadol (Tralieve (R)). Two established veterinary active pharmaceutical ingredients became available for additional species: the nonsteroidal anti-inflammatory drug Meloxicam (Metacam (R)) from the oxicam group for guinea pigs and the inhalant anesthetic Sevoflurane (Sevoflo (R)) from the group of halogenated hydrocarbon compounds, which has additionally been authorized for cats. With the combination of Benzylpenicillin-Benzathine and Benzylpenicillin-Procaine, one temporarily non-available combination of active ingredients was reapproved in new drugs. Additionally, one drug with a new pharmaceutical form and one drug with a higher content of the active ingredient have been launched on the market for small animals.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据